Loading...
OTCM
RHYBF
Market cap10mUSD
, Last price  
USD
Name

Rhythm Biosciences Ltd

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
14.12%
Rev. gr., 5y
10.46%
Revenues
2m
-45.41%
001,027,617100,0001,108,5072,427,4063,095,8421,690,144
Net income
-7m
L-16.56%
-72,127-1,753,480-1,377,475-4,130,780-7,721,051-6,316,185-8,217,557-6,856,761
CFO
-6m
L-11.79%
0-1,651,299-2,941,596-2,742,598-5,402,486-6,214,705-6,957,610-6,137,171
Earnings
Aug 28, 2025

Profile

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
IPO date
Dec 07, 2017
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑082017‑06
Income
Revenues
1,690
-45.41%
3,096
27.54%
Cost of revenue
6,727
11,343
Unusual Expense (Income)
NOPBT
(5,037)
(8,247)
NOPBT Margin
Operating Taxes
(1,690)
(228)
Tax Rate
NOPAT
(3,347)
(8,019)
Net income
(6,857)
-16.56%
(8,218)
30.10%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,897
3,716
BB yield
-20.47%
-4.09%
Debt
Debt current
78
85
Long-term debt
249
85
Deferred revenue
Other long-term liabilities
4
55
Net debt
(427)
(4,000)
Cash flow
Cash from operating activities
(6,137)
(6,958)
CAPEX
(82)
(99)
Cash from investing activities
(82)
(99)
Cash from financing activities
2,805
3,630
FCF
(2,169)
(9,233)
Balance
Cash
754
4,169
Long term investments
Excess cash
670
4,014
Stockholders' equity
867
5,874
Invested Capital
365
2,000
ROIC
ROCE
EV
Common stock shares outstanding
228,297
221,542
Price
0.06
-84.88%
0.41
-64.35%
Market cap
14,154
-84.42%
90,832
-63.17%
EV
13,728
86,832
EBITDA
(4,838)
(8,058)
EV/EBITDA
Interest
3
Interest/NOPBT